相似文献
1
Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
Isr J Med Sci. 1997 Apr;33(4):243-5.
2
Detection and significance of heparin-platelet factor 4 antibodies.
Semin Hematol. 2005 Jul;42(3 Suppl 3):S9-14. doi: 10.1053/j.seminhematol.2005.05.013.
3
Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
Am J Kidney Dis. 2009 Aug;54(2):361-74. doi: 10.1053/j.ajkd.2009.03.012. Epub 2009 May 29.
4
Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin.
Thromb Haemost. 1994 Oct;72(4):644-5.
5
6
Heparin-induced thrombocytopenia: molecular pathogenesis.
Thromb Haemost. 1999 Aug;82(2):448-56.
7
Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
Clin Exp Immunol. 1997 May;108(2):333-9. doi: 10.1046/j.1365-2249.1997.d01-1008.x.
8
Heparin-induced thrombocytopenia: diagnosis and management.
Circulation. 2004 Nov 2;110(18):e454-8. doi: 10.1161/01.CIR.0000147537.72829.1B.
9
Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
N Engl J Med. 2003 Mar 13;348(11):1067-9. doi: 10.1056/NEJM200303133481120.
10
Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
Neurology. 2005 Apr 12;64(7):1285-7. doi: 10.1212/01.WNL.0000156947.45112.16.
引用本文的文献
1
The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia.
Int J Mol Sci. 2018 Apr 2;19(4):1054. doi: 10.3390/ijms19041054.
Zotero 插件